- Home
- / Acer Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Acer Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
NT$154
2024-10-29
Market Capitalization
NT$2.3 B
2024-10-29
Revenue
NT$60.1 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 15, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| TWD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1.0M | 9.6M | 13.1M | 27.4M | 50.2M | 60.1M |
| Cost of goods sold | 582.0K | 3.1M | 6.2M | 13.3M | 17.3M | 21.3M |
| Gross profit | 432.0K | 6.5M | 6.9M | 14.3M | 33.1M | 38.9M |
| Gross profit margin, % | 42.6% | 67.6% | 52.5% | 52.2% | 66.1% | 64.7% |
| Operating expense total | 12.4M | 27.0M | 61.3M | 54.0M | 61.9M | 70.2M |
| Depreciation and amortization | 89.0K | 76.0K | 675.0K | 1.3M | 1.2M | 1.2M |
| EBITDA | (11.9M) | (20.5M) | (54.5M) | (39.7M) | (28.7M) | (31.4M) |
| EBITDA margin, % | -1176.4% | -212.5% | -416.9% | -144.7% | -57.3% | -52.3% |
| EBIT | (12.0M) | (20.5M) | (55.1M) | (41.0M) | (30.0M) | (32.5M) |
| EBIT margin, % | -1185.2% | -213.3% | -422.1% | -149.5% | -59.7% | -54.2% |
| Interest income | 100.0K | 93.0K | 434.0K | 2.9M | 2.6M | 2.6M |
| Interest expense | 1.0K | 13.0K | ||||
| Pre tax profit | (11.9M) | (20.4M) | (54.7M) | (38.2M) | (27.4M) | (29.7M) |
| Net Income | (11.9M) | (20.4M) | (54.7M) | (38.2M) | (27.4M) | (29.7M) |